Point72 (DIFC)’s West Pharmaceutical WST Stock Holding History

Point72 (DIFC)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,800	Closed	-$917K	–	2117
2024 Q4	$917K	Buy	2,800 +2,300	+460%	+$724K	0.03%	493
2024 Q3	$150K	Hold	500	–	–	0.01%	897
2024 Q2	$165K	Buy	500 +200	+67%	+$70.7K	0.01%	885
2024 Q1	$119K	Buy	+300	New	+$111K	﹤0.01%	1060

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Point72 (DIFC)'s WST Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in West Pharmaceutical (WST) in Q3 2025: 420 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #559 among its holdings.

756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

Point72 (DIFC) held 420 shares of West Pharmaceutical worth $110K as of Q3 2025.
West Pharmaceutical was a new Point72 (DIFC) position in Q3 2025.
West Pharmaceutical made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #559 holding.
756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.